Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in germany: Model analysis from the perspective of germany's statutory health insurance system
| Autor: | Neubauer, Aljoscha S., Holz, Frank G., Sauer, Stefan, Wasmuth, Timo, Hirneiss, Christoph, Kampik, Anselm, Schrader, Wolfgang |
|---|---|
| Zdroj: | In Clinical Therapeutics 2010 32(7):1343-1356 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect